Main menu

An end-to-end workflow for pharmacogenomic target enrichment, star allele annotation, and CYP2D6 resolution


LC2025 Pharmacogenetics PO_1245

Haplotype resolved variant calling, including CYP2D6 structural and copy number variations, through scalable Oxford Nanopore sequencing of pharmacogenetic gene panels and the EPI2ME wf-pgx analysis solution

Download the poster to discover:

  • How Oxford Nanopore adaptive sampling and the Twist Alliance Long-Read PGx Panel target and enrich pharmacogenes, allowing for scalable library preparation and streamlined analysis with wf-pgx
  • How The EPI2ME wf-pgx pipeline accurately genotypes CYP2D6 structural variants with Chinook, a targeted assembly method, and resolves SNV ambiguities in other pharmacogenes with PharmCAT

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag